Pretreatment with statins improves early outcome in patients with first-ever ischaemic stroke: a pleiotropic effect of statins or a beneficial effect of hypercholesterolemia?

<p>Abstract</p> <p>Background</p> <p>Data from different studies suggest a favourable association between pretreatment with statins or hypercholesterolemia and outcome after ischaemic stroke. We examined whether there were differences in in-hospital mortality according...

Full description

Bibliographic Details
Main Authors: Balcells Miquel, Targa Cecília, Oliveres Montserrat, García-Eroles Luis, Arboix Adrià, Massons Joan
Format: Article
Language:English
Published: BMC 2010-06-01
Series:BMC Neurology
Online Access:http://www.biomedcentral.com/1471-2377/10/47
id doaj-95ebf6c2966d4342bbe3deabdfe54e5c
record_format Article
spelling doaj-95ebf6c2966d4342bbe3deabdfe54e5c2020-11-25T01:36:25ZengBMCBMC Neurology1471-23772010-06-011014710.1186/1471-2377-10-47Pretreatment with statins improves early outcome in patients with first-ever ischaemic stroke: a pleiotropic effect of statins or a beneficial effect of hypercholesterolemia?Balcells MiquelTarga CecíliaOliveres MontserratGarcía-Eroles LuisArboix AdriàMassons Joan<p>Abstract</p> <p>Background</p> <p>Data from different studies suggest a favourable association between pretreatment with statins or hypercholesterolemia and outcome after ischaemic stroke. We examined whether there were differences in in-hospital mortality according to the presence or absence of statin therapy in a large population of first-ever ischaemic stroke patients and assessed the influence of statins upon early death and spontaneous neurological recovery.</p> <p>Methods</p> <p>In 2,082 consecutive patients with first-ever ischaemic stroke collected from a prospective hospital-based stroke registry during a period of 19 years (1986-2004), statin use or hypercholesterolemia before stroke was documented in 381 patients. On the other hand, favourable outcome defined as grades 0-2 in the modified Rankin scale was recorded in 382 patients.</p> <p>Results</p> <p>Early outcome was better in the presence of statin therapy or hypercholesterolemia (cholesterol levels were not measured) with significant differences between the groups with and without pretreatment with statins in in-hospital mortality (6% <it>vs </it>13.3%, <it>P </it>= 0.001) and symptom-free (22% <it>vs </it>17.5%, <it>P </it>= 0.025) and severe functional limitation (6.6% <it>vs </it>11.5%, <it>P </it>= 0.002) at hospital discharge, as well as lower rates of infectious respiratory complications during hospitalization. In the logistic regression model, statin therapy was the only variable inversely associated with in-hospital death (odds ratio 0.57) and directly associated with favourable outcome (odds ratio 1.32).</p> <p>Conclusions</p> <p>Use of statins or hypercholesterolemia before first-ever ischaemic stroke was associated with better early outcome with a reduced mortality during hospitalization and neurological disability at hospital discharge. However, statin therapy may increase the risk of intracerebral haemorrhage, particularly in the setting of thrombolysis.</p> http://www.biomedcentral.com/1471-2377/10/47
collection DOAJ
language English
format Article
sources DOAJ
author Balcells Miquel
Targa Cecília
Oliveres Montserrat
García-Eroles Luis
Arboix Adrià
Massons Joan
spellingShingle Balcells Miquel
Targa Cecília
Oliveres Montserrat
García-Eroles Luis
Arboix Adrià
Massons Joan
Pretreatment with statins improves early outcome in patients with first-ever ischaemic stroke: a pleiotropic effect of statins or a beneficial effect of hypercholesterolemia?
BMC Neurology
author_facet Balcells Miquel
Targa Cecília
Oliveres Montserrat
García-Eroles Luis
Arboix Adrià
Massons Joan
author_sort Balcells Miquel
title Pretreatment with statins improves early outcome in patients with first-ever ischaemic stroke: a pleiotropic effect of statins or a beneficial effect of hypercholesterolemia?
title_short Pretreatment with statins improves early outcome in patients with first-ever ischaemic stroke: a pleiotropic effect of statins or a beneficial effect of hypercholesterolemia?
title_full Pretreatment with statins improves early outcome in patients with first-ever ischaemic stroke: a pleiotropic effect of statins or a beneficial effect of hypercholesterolemia?
title_fullStr Pretreatment with statins improves early outcome in patients with first-ever ischaemic stroke: a pleiotropic effect of statins or a beneficial effect of hypercholesterolemia?
title_full_unstemmed Pretreatment with statins improves early outcome in patients with first-ever ischaemic stroke: a pleiotropic effect of statins or a beneficial effect of hypercholesterolemia?
title_sort pretreatment with statins improves early outcome in patients with first-ever ischaemic stroke: a pleiotropic effect of statins or a beneficial effect of hypercholesterolemia?
publisher BMC
series BMC Neurology
issn 1471-2377
publishDate 2010-06-01
description <p>Abstract</p> <p>Background</p> <p>Data from different studies suggest a favourable association between pretreatment with statins or hypercholesterolemia and outcome after ischaemic stroke. We examined whether there were differences in in-hospital mortality according to the presence or absence of statin therapy in a large population of first-ever ischaemic stroke patients and assessed the influence of statins upon early death and spontaneous neurological recovery.</p> <p>Methods</p> <p>In 2,082 consecutive patients with first-ever ischaemic stroke collected from a prospective hospital-based stroke registry during a period of 19 years (1986-2004), statin use or hypercholesterolemia before stroke was documented in 381 patients. On the other hand, favourable outcome defined as grades 0-2 in the modified Rankin scale was recorded in 382 patients.</p> <p>Results</p> <p>Early outcome was better in the presence of statin therapy or hypercholesterolemia (cholesterol levels were not measured) with significant differences between the groups with and without pretreatment with statins in in-hospital mortality (6% <it>vs </it>13.3%, <it>P </it>= 0.001) and symptom-free (22% <it>vs </it>17.5%, <it>P </it>= 0.025) and severe functional limitation (6.6% <it>vs </it>11.5%, <it>P </it>= 0.002) at hospital discharge, as well as lower rates of infectious respiratory complications during hospitalization. In the logistic regression model, statin therapy was the only variable inversely associated with in-hospital death (odds ratio 0.57) and directly associated with favourable outcome (odds ratio 1.32).</p> <p>Conclusions</p> <p>Use of statins or hypercholesterolemia before first-ever ischaemic stroke was associated with better early outcome with a reduced mortality during hospitalization and neurological disability at hospital discharge. However, statin therapy may increase the risk of intracerebral haemorrhage, particularly in the setting of thrombolysis.</p>
url http://www.biomedcentral.com/1471-2377/10/47
work_keys_str_mv AT balcellsmiquel pretreatmentwithstatinsimprovesearlyoutcomeinpatientswithfirsteverischaemicstrokeapleiotropiceffectofstatinsorabeneficialeffectofhypercholesterolemia
AT targacecilia pretreatmentwithstatinsimprovesearlyoutcomeinpatientswithfirsteverischaemicstrokeapleiotropiceffectofstatinsorabeneficialeffectofhypercholesterolemia
AT oliveresmontserrat pretreatmentwithstatinsimprovesearlyoutcomeinpatientswithfirsteverischaemicstrokeapleiotropiceffectofstatinsorabeneficialeffectofhypercholesterolemia
AT garciaerolesluis pretreatmentwithstatinsimprovesearlyoutcomeinpatientswithfirsteverischaemicstrokeapleiotropiceffectofstatinsorabeneficialeffectofhypercholesterolemia
AT arboixadria pretreatmentwithstatinsimprovesearlyoutcomeinpatientswithfirsteverischaemicstrokeapleiotropiceffectofstatinsorabeneficialeffectofhypercholesterolemia
AT massonsjoan pretreatmentwithstatinsimprovesearlyoutcomeinpatientswithfirsteverischaemicstrokeapleiotropiceffectofstatinsorabeneficialeffectofhypercholesterolemia
_version_ 1725063091141476352